Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8246708 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 8 Pages |
Abstract
Conclusions: These preclinical studies suggest that ZD6126 can augment the radiation response of proliferating endothelial H&N and lung cancer cells. These results complement recent reports suggesting the potential value of combining radiation with vascular targeting/antiangiogenic agents.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Tien M.D., Shyhmin Ph.D., Eric M.S., Jens C. Ph.D., Paul M. M.D.,